Vietnam.vn - Nền tảng quảng bá Việt Nam

Russia: Cancer vaccine reduces tumors by 80% pending clinical use license

Ms. Veronika Skvortsova, Director of the Russian Federal Medical-Biological Agency (FMBA), former Minister of Health of Russia, has just announced that Russia's new cancer vaccine is waiting for the Ministry of Health of this country to license for clinical use.

Báo Thanh niênBáo Thanh niên07/09/2025

After preclinical trials of this new anti-cancer vaccine were successful in both safety and high efficacy.

The vaccine has undergone three years of international preclinical studies, which have shown it to be completely safe even after repeated injections, and highly effective in inhibiting tumor growth.

The results were astonishing, with tumor size and growth rates reduced by 60-80%. Remarkably, the vaccine also significantly improved patient survival rates.

Vắc xin ung thư giảm 80% khối u đã sẵn sàng sử dụng trong năm nay - Ảnh 1.

The highlight of this vaccine is its ability to directly affect the immune system, helping the body recognize and fight cancer cells.

Illustration: AI

Pending clinical approval

By the end of the summer of 2025, FMBA submitted all the documents to the Russian Ministry of Health to request permission to use the vaccine on patients. This means that in a very short time, if approved, the vaccine could begin testing in hospitals and oncology centers, according to TASS news agency.

The first target is colorectal cancer.

In the first phase, the vaccine is being targeted at colorectal cancer - one of the most common cancers in the world. In parallel, scientists are also perfecting the development of vaccines against glioblastoma - one of the most malignant tumors, and special types of melanoma.

Cancer vaccine ready for use

According to Ms. Skvortsova, the highlight of this vaccine is its ability to directly affect the immune system, helping the body recognize and fight cancer cells. This is a new direction compared to traditional methods such as chemotherapy or radiotherapy.

The vaccine is ready for use, we are just waiting for the license, Skvortsova said. If it is implemented in clinical practice, it could become one of the most important breakthroughs in Russian medicine in cancer treatment.

Source: https://thanhnien.vn/nga-vac-xin-ung-thu-giam-80-khoi-u-da-san-sang-su-dung-185250907160008105.htm


Comment (0)

No data
No data

Same tag

Same category

Lost in cloud hunting in Ta Xua
There is a hill of purple Sim flowers in the sky of Son La
Lantern - A Mid-Autumn Festival gift in memory
Tò he – from a childhood gift to a million-dollar work of art

Same author

Heritage

;

Figure

;

Enterprise

;

No videos available

News

;

Political System

;

Destination

;

Product

;